Mohamad-Ali Salloum is a Pharmacist and science writer. He loves simplifying science to the general public and healthcare students through words and illustrations. When he's not working, you can usually find him in the gym, reading a book, or learning a new skill.
Understanding Sickle Cell Disease, Pathophysiology, and Its Treatments
Mohamad-Ali Salloum, PharmD • July 12, 2024
Share
Pathophysiology and Molecular Biology
- Hydroxyurea: This medication increases the production of fetal hemoglobin (HbF), a type of hemoglobin that does not sickle. By increasing HbF levels, hydroxyurea reduces the frequency of pain crises and the need for blood transfusions. For example, a patient taking hydroxyurea may experience fewer episodes of severe pain compared to someone not on the medication.
- Blood Transfusions: Regular blood transfusions can help reduce the risk of stroke and other complications by increasing the number of normal red blood cells in circulation. For instance, a child with a high risk of stroke may receive monthly blood transfusions to lower this risk.
- Pain Management: Pain crises are a common and debilitating symptom of SCD. Pain management strategies include over-the-counter pain relievers like ibuprofen, prescription opioids, and non-pharmacological methods such as heating pads and hydration. For example, a patient experiencing a pain crisis might use a combination of ibuprofen and a heating pad to alleviate pain.
- Bone Marrow Transplant: This is currently the only potential cure for SCD. It involves replacing the patient’s bone marrow with healthy marrow from a compatible donor. However, this procedure carries significant risks and is not suitable for all patients. For instance, a young patient with a severe form of SCD might undergo a bone marrow transplant if a suitable donor is found.
- Gene Therapy: This approach aims to correct the genetic mutation responsible for SCD. One method involves using a virus to deliver a normal copy of the HBB gene to the patient’s bone marrow cells. For example, a patient undergoing gene therapy might have their bone marrow cells modified to produce normal hemoglobin, potentially curing the disease.
- CRISPR-Cas9: This gene-editing technology can precisely target and modify specific genes. Researchers are exploring its use to correct the sickle cell mutation or to increase the production of fetal hemoglobin. For instance, a patient treated with CRISPR-Cas9 might have their genes edited to produce more HbF, reducing the severity of their symptoms.
- Voxelotor: This medication works by increasing the affinity of hemoglobin for oxygen, preventing the polymerization of HbS and the sickling of red blood cells. For example, a patient taking voxelotor might experience fewer vaso-occlusive crises compared to someone not on the medication.
- L-glutamine: This amino acid supplement has been shown to reduce the frequency of pain crises in patients with SCD. For instance, a patient taking L-glutamine might have fewer hospitalizations due to pain crises.
Comparison of Treatment Mechanisms
- Hydroxyurea: This medication increases the production of fetal hemoglobin (HbF), which does not sickle. By increasing HbF levels, hydroxyurea reduces the frequency of pain crises and the need for blood transfusions. For example, a patient taking hydroxyurea may experience fewer episodes of severe pain compared to someone not on the medication.
- Voxelotor: This medication works by increasing the affinity of hemoglobin for oxygen, preventing the polymerization of HbS and the sickling of red blood cells. For example, a patient taking voxelotor might experience fewer vaso-occlusive crises compared to someone not on the medication.
Resources:
- Mayo Clinic. Sickle cell anemia - Symptoms & causes: https://www.mayoclinic.org/diseases-conditions/sickle-cell-anemia/symptoms-causes/syc-20355876.
- Cleveland Clinic. Sickle Cell Disease (SCD): Types, Symptoms & Causes: https://my.clevelandclinic.org/health/diseases/12100-sickle-cell-disease
- Johns Hopkins Medicine. Sickle Cell Disease: https://www.hopkinsmedicine.org/health/conditions-and-diseases/sickle-cell-disease
- CDC. About Sickle Cell Disease: https://www.cdc.gov/sickle-cell/about/index.html
- NHLBI, NIH. Sickle Cell Disease - Causes and Risk Factors: https://www.nhlbi.nih.gov/health/sickle-cell-disease/causes
- Oxford Academic. Sickle-Cell Anemia Hemoglobin: The Molecular Biology of the First: https://academic.oup.com/genetics/article/167/1/1/6050610
- Blood Advances. Metabolomic and molecular insights into sickle cell disease and innovative therapies: https://ashpublications.org/bloodadvances/article/3/8/1347/260127/Metabolomic-and-molecular-insights-into-sickle
- Science News Explores. Explainer: What is sickle cell disease?: https://www.snexplores.org/article/explainer-what-is-sickle-cell-disease
- NHS. Sickle cell disease - Diagnosis: https://www.nhs.uk/conditions/sickle-cell-disease/diagnosis/
- Springer. Pathophysiology and recent therapeutic insights of sickle cell disease: https://link.springer.com/article/10.1007/s00277-020-03977-9
- Drugs.com. How does Endari work to treat sickle cell disease?: https://www.drugs.com/medical-answers/endari-work-treat-sickle-cell-disease-3323440/
List of Services
ABOUT THE AUTHOR
Mohamad-Ali Salloum, PharmD
Share
Recent articles:

References : American Chemical Society. Tramadol – Molecule of the Week Archive. December 16, 2014. [acs.org] DEA Diversion Control Division. Tramadol Drug & Chemical Evaluation Section Report. April 2025. [deadiversi....usdoj.gov] Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879‑923. [go.drugbank.com] Food and Drug Administration (FDA). ULTRAM® (tramadol hydrochloride) tablets label. 2004. [accessdata.fda.gov] Nickson C. Tramadol – CCC Pharmacology. Life in the Fast Lane ; 2024. [litfl.com] DrugBank Online. Tramadol: Uses, Interactions, Mechanism of Action. DB00193. [go.drugbank.com] Food and Drug Administration (FDA). Tramadol Hydrochloride Tablets (DailyMed). 2023. [dailymed.nlm.nih.gov] Dean L. Tramadol Therapy and CYP2D6 Genotype. Medical Genetics Summaries . 2015. [ncbi.nlm.nih.gov] Food and Drug Administration (FDA). Tramadol ER Capsules Label Information. 2010. [accessdata.fda.gov] EBM Consult. Mechanism for Tramadol‑Induced Serotonin Syndrome in Patients Taking SSRIs. 2017. Medsafe Pharmacovigilance. Serious Reactions with Tramadol: Seizures and Serotonin Syndrome. 2007. Hassamal S, Miotto K, Dale W, Danovitch I. Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures. Am J Med. 2018;131(11):1382.e1–6. Medscape Reference. Ultram, ConZip (tramadol) dosing, indications, interactions. 2026.

References: Qiang S, Wu J, Zheng D, et al. The effect of stress mindset on psychological pain: the chain mediating roles of cognitive reappraisal and self-identity. Front Psychol. 2025;16. 1 Bosshard M, Gomez P. Effectiveness of stress arousal reappraisal and stressisenhancing mindset interventions on task performance outcomes: a meta-analysis. Sci Rep. 2024. 2 Zhao S, Chen P, Jin L, et al. Unlocking Emotional Well-Being: Evaluation of a Stress Mindset Intervention With a Metacognitive Approach. Emotion. 2025;25(5):1169–1184. 4 Meyer HH, Stutts LA. The Effect of Mindset Interventions on Stress and Academic Motivation in College Students. Innov High Educ. 2024;49:783–798. 7 Crum AJ, Santoro E, Handley-Miner I, et al. Evaluation of the “Rethink Stress” Mindset Intervention: A Metacognitive Approach to Changing Mindsets. J Exp Psychol Gen. 2023. 3 Laferton JAC, Fischer S, Ebert DD, et al. The Effects of Stress Beliefs on Daily Affective Stress Responses. Ann Behav Med. 2020;54(4):258–267. 5 UCSF Stress Measurement Network. Beliefs about Stress . 2026. 6

References: Qiang S, Wu J, Zheng D, et al. The effect of stress mindset on psychological pain: the chain mediating roles of cognitive reappraisal and self-identity. Front Psychol. 2025;16. 1 Bosshard M, Gomez P. Effectiveness of stress arousal reappraisal and stressisenhancing mindset interventions on task performance outcomes: a meta-analysis. Sci Rep. 2024. 2 Zhao S, Chen P, Jin L, et al. Unlocking Emotional Well-Being: Evaluation of a Stress Mindset Intervention With a Metacognitive Approach. Emotion. 2025;25(5):1169–1184. 4 Meyer HH, Stutts LA. The Effect of Mindset Interventions on Stress and Academic Motivation in College Students. Innov High Educ. 2024;49:783–798. 7 Crum AJ, Santoro E, Handley-Miner I, et al. Evaluation of the “Rethink Stress” Mindset Intervention: A Metacognitive Approach to Changing Mindsets. J Exp Psychol Gen. 2023. 3 Laferton JAC, Fischer S, Ebert DD, et al. The Effects of Stress Beliefs on Daily Affective Stress Responses. Ann Behav Med. 2020;54(4):258–267. 5 UCSF Stress Measurement Network. Beliefs about Stress . 2026. 6













